metricas
covid
Neurology perspectives Ocrelizumab reduces progression of brain atrophy in patients with multiple scler...
Journal Information

Statistics

Follow this link to access the full text of the article

Original article
Ocrelizumab reduces progression of brain atrophy in patients with multiple sclerosis
Ocrelizumab reduce la progresion de la atrofia cerebral en pacientes con esclerosis multiple
D.A.G. Estévez
Corresponding author
Daniel.apolinar.garcia.estevez@sergas.es

Corresponding author at: Servicio de Neurología, Complejo Hospitalario Universitario de Ourense, c/ Ramón Puga, 52, 32005 Ourense, Spain.
Servicio de Neurología, Complejo Hospitalario Universitario de Ourense, 32005 Ourense, Spain
Grupo de Investigación en Neurociencias Clínicas, Instituto de Investigación Sanitaria Galicia Sur (IIS Galicia Sur), SERGAS-UVIGO, Spain
Read
228
Times
was read the article
76
Total PDF
152
Total HTML
Share statistics
Article information
ISSN: 26670496
Original language: English
The statistics are updated each day
Year/Month Html Pdf Total
2025 12 124 49 173
2025 11 28 27 55

Follow this link to access the full text of the article